On the other hand, hyperinsulinemia also leads to the activation of mTOR and mitogen-activated protein kinase (MARK) signaling pathway, which further leads to the growth of cancer cells and resistance to neoadjuvant therapy [40]. This evidence concerns the gene WNK2 and cancer.